ALLK
Price
$1.13
Change
+$0.08 (+7.62%)
Updated
May 1, 6:59 PM EST
6 days until earnings call
PRME
Price
$5.27
Change
+$0.35 (+7.11%)
Updated
May 1, 6:59 PM EST
8 days until earnings call
Ad is loading...

ALLK vs PRME ᐉ Comparison: Which is Better to Invest?

Header iconALLK vs PRME Comparison
Open Charts ALLK vs PRMEBanner chart's image
Allakos
Price$1.13
Change+$0.08 (+7.62%)
Volume$254.24K
CapitalizationN/A
Prime Medicine
Price$5.27
Change+$0.35 (+7.11%)
Volume$503.33K
CapitalizationN/A
View a ticker or compare two or three
ALLK vs PRME Comparison Chart

Loading...

ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLK vs. PRME commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and PRME is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (ALLK: $1.05 vs. PRME: $4.92)
Brand notoriety: ALLK and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 61% vs. PRME: 175%
Market capitalization -- ALLK: $92.97M vs. PRME: $589.94M
ALLK [@Biotechnology] is valued at $92.97M. PRME’s [@Biotechnology] market capitalization is $589.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALLK and PRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 6 TA indicator(s) are bullish while PRME’s TA Score has 5 bullish TA indicator(s).

  • ALLK’s TA Score: 6 bullish, 2 bearish.
  • PRME’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ALLK is a better buy in the short-term than PRME.

Price Growth

ALLK (@Biotechnology) experienced а 0.00% price change this week, while PRME (@Biotechnology) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.37%. For the same industry, the average monthly price growth was -4.20%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

ALLK is expected to report earnings on Aug 05, 2024.

PRME is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Biotechnology (+3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLK with price predictions.
OPEN
A.I.dvisor published
a Summary for PRME with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PRME($590M) has a higher market cap than ALLK($93M). PRME YTD gains are higher at: -44.470 vs. ALLK (-61.538).
ALLKPRMEALLK / PRME
Capitalization93M590M16%
EBITDAN/AN/A-
Gain YTD-61.538-44.470138%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
ALLKPRME
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ALLKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PRMEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VPRAX26.74-0.30
-1.11%
VY® T. Rowe Price Capital Apprec R6
MALVX31.35-0.47
-1.48%
BlackRock Advantage Large Cap Val Instl
RWGFX4.48-0.07
-1.54%
Wedgewood Retail
NBNGX21.98-0.41
-1.83%
Sit Mid Cap Growth
RYATX65.15-1.28
-1.93%
Rydex NASDAQ-100® A

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
-4.55%
AXON - ALLK
38%
Loosely correlated
+0.11%
VIR - ALLK
34%
Loosely correlated
+1.08%
PRME - ALLK
34%
Loosely correlated
+1.23%
AKRO - ALLK
33%
Loosely correlated
+1.38%
IMCR - ALLK
33%
Loosely correlated
+1.69%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+1.23%
BEAM - PRME
63%
Loosely correlated
-3.76%
NTLA - PRME
62%
Loosely correlated
-2.64%
RLAY - PRME
54%
Loosely correlated
-1.06%
XNCR - PRME
53%
Loosely correlated
-0.62%
ABCL - PRME
51%
Loosely correlated
-1.56%
More